We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
4 similar Equity Sales Agreement contracts by Pfenex Inc., Accelerate Diagnostics, Inc, Potbelly Corp
POTBELLY CORPORATION Common Stock (par value $0.01 per share) Equity Sales AgreementEquity Sales Agreement • November 4th, 2021 • Potbelly Corp • Retail-eating places • New York
Potbelly Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with William Blair & Company, L.L.C. (the “Agent”) as follows:
Standard Contracts
ACCELERATE DIAGNOSTICS, INC. Common Stock (par value $0.001 per share) Equity Sales AgreementEquity Sales Agreement • May 28th, 2021 • Accelerate Diagnostics, Inc • Laboratory analytical instruments • New York
Accelerate Diagnostics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with William Blair & Company, L.L.C. (the “Agent”) as follows:
PFENEX INC. Common Stock (par value $0.001 per share) Equity Sales AgreementEquity Sales Agreement • May 7th, 2020 • Pfenex Inc. • Pharmaceutical preparations • New York
Pfenex Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with each of William Blair & Company, L.L.C. and H.C. Wainwright & Co., LLC (each, an “Agent,” and together, the “Agents”) as follows:
PFENEX INC. Common Stock (par value $0.001 per share) Equity Sales AgreementEquity Sales Agreement • March 15th, 2018 • Pfenex Inc. • Pharmaceutical preparations • New York
Pfenex Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with William Blair & Company, L.L.C. (the “Agent”) as follows: